OWENS & MINOR INC (OMI) Stock Fundamental Analysis
NYSE:OMI - New York Stock Exchange, Inc. - US6907321029 - Common Stock - Currency: USD
Overall OMI gets a fundamental rating of 4 out of 10. We evaluated OMI against 102 industry peers in the Health Care Providers & Services industry. OMI has a medium profitability rating, but doesn't score so well on its financial health evaluation. A decent growth rate in combination with a cheap valuation! Better keep an eye on OMI.
1. Profitability
1.1 Basic Checks
OMI had positive earnings in the past year.
In the past year OMI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: OMI reported negative net income in multiple years.
In the past 5 years OMI always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of -7.53%, OMI is not doing good in the industry: 73.53% of the companies in the same industry are doing better.
With a Return On Equity value of -64.06%, OMI is not doing good in the industry: 73.53% of the companies in the same industry are doing better.
OMI has a better Return On Invested Capital (7.06%) than 69.61% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for OMI is below the industry average of 9.62%.
The last Return On Invested Capital (7.06%) for OMI is above the 3 year average (6.37%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.53% | ||
| ROE | -64.06% | ||
| ROIC | 7.06% |
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
1.3 Margins
OMI has a Operating Margin (2.41%) which is in line with its industry peers.
In the last couple of years the Operating Margin of OMI has grown nicely.
OMI has a Gross Margin (20.61%) which is comparable to the rest of the industry.
OMI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.41% | ||
| PM (TTM) | N/A | ||
| GM | 20.61% |
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
2. Health
2.1 Basic Checks
OMI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for OMI has been increased compared to 1 year ago.
The number of shares outstanding for OMI has been increased compared to 5 years ago.
The debt/assets ratio for OMI has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.53 indicates that OMI is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.53, OMI perfoms like the industry average, outperforming 55.88% of the companies in the same industry.
OMI has a Debt/Equity ratio of 3.32. This is a high value indicating a heavy dependency on external financing.
OMI has a worse Debt to Equity ratio (3.32) than 79.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.32 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.53 |
ROIC/WACC0.88
WACC8.05%
2.3 Liquidity
A Current Ratio of 1.13 indicates that OMI should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.13, OMI is doing worse than 65.69% of the companies in the same industry.
A Quick Ratio of 0.41 indicates that OMI may have some problems paying its short term obligations.
OMI's Quick ratio of 0.41 is on the low side compared to the rest of the industry. OMI is outperformed by 90.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.41 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 4.00% over the past year.
Measured over the past years, OMI shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.10% on average per year.
Looking at the last year, OMI shows a small growth in Revenue. The Revenue has grown by 2.84% in the last year.
OMI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.04% yearly.
EPS 1Y (TTM)4%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%21.05%
Revenue 1Y (TTM)2.84%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%0.74%
3.2 Future
Based on estimates for the next years, OMI will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.25% on average per year.
The Revenue is expected to grow by 3.36% on average over the next years.
EPS Next Y12.03%
EPS Next 2Y12.58%
EPS Next 3Y18.51%
EPS Next 5Y14.25%
Revenue Next Year3.55%
Revenue Next 2Y3.33%
Revenue Next 3Y3.36%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 4.99 indicates a rather cheap valuation of OMI.
Based on the Price/Earnings ratio, OMI is valued cheaper than 99.02% of the companies in the same industry.
OMI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.31.
OMI is valuated cheaply with a Price/Forward Earnings ratio of 4.04.
Based on the Price/Forward Earnings ratio, OMI is valued cheaper than 98.04% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.13, OMI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.99 | ||
| Fwd PE | 4.04 |
4.2 Price Multiples
OMI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. OMI is cheaper than 92.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.87 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OMI's earnings are expected to grow with 18.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.42
PEG (5Y)0.23
EPS Next 2Y12.58%
EPS Next 3Y18.51%
5. Dividend
5.1 Amount
No dividends for OMI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.79
-0.18 (-2.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.66%
Inst Owner Change-1.47%
Ins Owners3.64%
Ins Owner Change19.56%
Market Cap596.79M
Analysts48.33
Price Target10.2 (30.94%)
Short Float %9.71%
Short Ratio4.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.75%
Min EPS beat(2)4.84%
Max EPS beat(2)16.66%
EPS beat(4)4
Avg EPS beat(4)7.71%
Min EPS beat(4)0.62%
Max EPS beat(4)16.66%
EPS beat(8)8
Avg EPS beat(8)7%
EPS beat(12)10
Avg EPS beat(12)15.12%
EPS beat(16)14
Avg EPS beat(16)15.59%
Revenue beat(2)0
Avg Revenue beat(2)-1.28%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-0.59%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)0.52%
Revenue beat(8)2
Avg Revenue beat(8)-0.38%
Revenue beat(12)5
Avg Revenue beat(12)0.33%
Revenue beat(16)8
Avg Revenue beat(16)0.48%
PT rev (1m)-4.94%
PT rev (3m)-17.81%
EPS NQ rev (1m)-13.79%
EPS NQ rev (3m)-14.31%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.57%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)0.44%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.99 | ||
| Fwd PE | 4.04 | ||
| P/S | 0.06 | ||
| P/FCF | N/A | ||
| P/OCF | 3.33 | ||
| P/B | 1.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.87 |
EPS(TTM)1.56
EY20.03%
EPS(NY)1.93
Fwd EY24.73%
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)2.34
OCFY30.06%
SpS139.93
BVpS7.45
TBVpS-13.65
PEG (NY)0.42
PEG (5Y)0.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.53% | ||
| ROE | -64.06% | ||
| ROCE | 8.93% | ||
| ROIC | 7.06% | ||
| ROICexc | 7.21% | ||
| ROICexgc | 16.76% | ||
| OM | 2.41% | ||
| PM (TTM) | N/A | ||
| GM | 20.61% | ||
| FCFM | N/A |
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
ROICexc(3y)6.65%
ROICexc(5y)8.97%
ROICexgc(3y)17.92%
ROICexgc(5y)17.9%
ROCE(3y)8.06%
ROCE(5y)10.94%
ROICexcg growth 3Y-4.88%
ROICexcg growth 5Y26.45%
ROICexc growth 3Y-21.55%
ROICexc growth 5Y13.72%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
F-Score3
Asset Turnover2.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.32 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.72 | ||
| Cap/Depr | 96.66% | ||
| Cap/Sales | 2.27% | ||
| Interest Coverage | 1.72 | ||
| Cash Conversion | 35.14% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.41 | ||
| Altman-Z | 2.53 |
F-Score3
WACC8.05%
ROIC/WACC0.88
Cap/Depr(3y)77.12%
Cap/Depr(5y)69.93%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%21.05%
EPS Next Y12.03%
EPS Next 2Y12.58%
EPS Next 3Y18.51%
EPS Next 5Y14.25%
Revenue 1Y (TTM)2.84%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%0.74%
Revenue Next Year3.55%
Revenue Next 2Y3.33%
Revenue Next 3Y3.36%
Revenue Next 5YN/A
EBIT growth 1Y-16.96%
EBIT growth 3Y-14.84%
EBIT growth 5Y19.2%
EBIT Next Year97.3%
EBIT Next 3Y34.82%
EBIT Next 5YN/A
FCF growth 1Y-132.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-55.56%
OCF growth 3Y9.15%
OCF growth 5Y-0.56%